Vetoquinol Universal Registration Document 2019

60   Vetoquinol  Universal Registration Document 2019  Financial report 6 CONSOLIDATED FINANCIAL STATEMENTS Consolidated statement of comprehensive income 6.1 Consolidated statement of comprehensive income €000 Notes 2019 2018 Sales 6.5.8 395,990 367,941 Purchases consumed (124,526) (112,853) Other purchases and external expenses 6.5.10 (81,442) (78,662) Staff costs 6.5.11 (122,818) (115,325) Taxes other than on income (5,689) (4,962) Depreciation and impairment of fixed assets 6.5.20/6.5.21 (11,522) (10,090) Depreciation and impairment of fixed assets - IFRS 16 (4,792) Provisions and write-backs (876) (89) Other operating income 6.5.13 6,043 6,199 Other operating expenses 6.5.13 (1,483) (977) EBIT BEFORE AMORTIZATION OF ACQUIRED ASSETS 48,886 51,183 % of sales 12.3% 13.9% Amortization of acquired intangible assets (2,982) (2,748) EBIT 45,903 48,435 % of sales 11.6% 13.2% Non-recurring operating income and expenses 6.5.14 (5,018) (215) OPERATING INCOME 40,886 48,221 % of sales 10.3% 13.1% Income from cash and cash equivalents 6.5.16 280 439 Gross cost of debt 6.5.16 (217) (190) Interest paid - Lease liabilities (165) NET (COST OF DEBT)/INCOME FROM CASH AND CASH EQUIVALENTS 6.5.16 (102) 249 Other financial income 6.5.16 2,448 2,403 Other financial expenses 6.5.16 (2,551) (2,291) NET FINANCIAL INCOME/(EXPENSE) 6.5.16 (205) 361 INCOME BEFORE TAX 40,681 48,581 Income tax expense 6.5.17 (12,464) (12,171) NET INCOME FOR THE YEAR 28,247 36,226 Attributable to: Parent company shareholders 28,589 36,259 Non-controlling (minority) interests (342) (33) Exchange differences on translation of foreign operations reclas- sifiable to P/L 1,603 (2,116) Post-tax actuarial gains (losses) not reclassified to P/L (554) 282 Other comprehensive income, net of tax - - Total comprehensive income for the year, net of tax 29,296 34,392 Attributable to: Parent company shareholders 29,654 34,425 Non-controlling (minority) interests (358) (32) Basic EPS (€) 6.5.18 2.42 3.06 Diluted EPS (€) 6.5.18 2.42 3.07 Operating income 40,886 48,221 Provisions and write-backs recorded under non-recurring opera- ting income and expenses 4,372 (759) Provisions and write-backs 876 89 Depreciation and impairment of fixed assets 14,504 12,838 Depreciation and impairment of fixed assets - IFRS 16 4,792 - EBITDA 65,429 60,389 % of sales 16.5% 16.4%